Press Release

Covidien Implements a Voluntary Recall of Certain Lots of Shiley™ Adult Tracheostomy Tubes


BOULDER, CO – August 4, 2012-- Covidien today announced that it notified customers on July 18, 2012, about a voluntary global recall of certain lots of its Shiley™ reusable cannula, cuffed adult tracheostomy tubes, size 8. This action was in response to reports of volume leakage and/or disconnection between the inner and outer cannulae.

Customers are instructed to return all Shiley 8LPC and 8FEN tracheostomy tubes from the affected lots. If one of the recalled tubes is already in use in a patient, the Company recommends that the tube be replaced as soon as clinically appropriate as determined by the patient’s physician. If the physician advises leaving the tracheostomy tube in place, the Company strongly encourages that the frequency of direct patient observation be increased.

Only certain lots of the size 8 adult, reusable tracheostomy tubes are included in this product recall. All other sizes and styles of Shiley™ tracheostomy tubes are unaffected by this action. These tracheostomy tubes were distributed from October 2009 through June 2012.

Worldwide Product Codes

Product Code

Lot Number

Lot Number













This voluntary recall was initiated following an analysis by Covidien of customer reports of volume leakage and/or disconnection between the inner and outer cannula involving these specific tracheostomy tubes. These events were typically observed during mechanical ventilation and represent a small fraction of the tubes distributed. Volume leakage and/or disconnection could impact ventilation

Covidien has alerted customers by mail of its voluntary recall action and provided instructions on returning the devices. The U.S. Food and Drug Administration and other regulatory bodies have also been notified.
Replacements for the affected lots of product are expected to be available soon. Alternative Covidien products to meet customer needs for the impacted product codes are available.

Adverse reactions experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by phone or fax.

For information or to report a problem, please contact:

  • Covidien Technical Services at (800) 635-5267, option 3, then option 1. Support is available during business hours with emergency service support available after these times.


Rhonda Luniak       Bruce Farmer
Vice President, Communications       Vice President
Respiratory & Monitoring Solutions       Public Relations
(303) 305-2263 or (303) 406-8743       (508) 452-4372
Coleman Lannum, CFA       Todd Carpenter
Vice President       Director
Investor Relations       Investor Relations
(508) 452-4343       (508) 452-4363